Find Technologies

  • The Use of Recombinant Cholera Toxin-B for the Treatment of Inflammatory Bowel Disease
    •
       Ref: E-263-1999-0 | Updated: Jul 16, 2010 | NIAID
  • Safer Attenuated Virus Vaccines with Missing or Diminished Latency of Infection
    •
       Ref: E-217-2004-0 | Updated: Jul 09, 2013 | NIAID
  • Novel Epstein-Barr Virus Vaccines
    •
       Ref: E-531-2013-0 | Updated: Dec 17, 2015 | NIAID
  • LRRK2 Inhibitors: Novel Treatment for Intestinal Bowel Disorders
    •
       Ref: E-070-2014-0 | Updated: Mar 22, 2016 | NIAID
  • Methods Of Treating Established Colitis Using Antibodies Against IL-12
    •
       Ref: E-097-1995-0 | Updated: Jul 01, 1996 | NIAID
  • Resurfaced Stabilized Core 3 (RSC3) Protein, Derived Proteins, and DNA Encoding These Proteins: RSC3, RSC3 delta371I, RSC3 delta371I/P363N, RSC3 G367R
    •
       Ref: E-236-2016-0 | Updated: Jun 07, 2018 | NIAID
  • Prefusion HPIV F Immunogens and Their Use.
    •    Ref: E-215-2016-0 | Updated: Aug 31, 2018 | NIAID
  • Antibodies and Methods for the Diagnosis and Treatment of Epstein-Barr Virus Infection
    •    Ref: E-001-2017-0 | Updated: Sep 21, 2020 | NIAID
  • Recombinant HIV-1 Envelope Proteins and Their Use
    •
       Ref: E-240-2017-0 | Updated: Sep 05, 2019 | NIAID
  • Chimeric Adaptor Proteins (CAPs) Containing a Linker for Activation of T Cells (LAT) and a Kinase Domain for Use in T Cell-Based Immunotherapy
    •
       Ref: E-210-2018 | Updated: May 19, 2020 | NCI
  • A Method to Isolate Tumor Specific T-Cells or T-Cell Receptors from Peripheral Blood using In-vitro Stimulation of Memory T-Cells
    •
       Ref: E-238-2017 | Updated: Jun 28, 2019 | NCI
  • Improved CD22 Binders for Effective Immunotherapy Against Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)
    •
       Ref: E-161-2018 | Updated: Jun 30, 2020 | NCI
  • Use of the TP5 Peptide for the Treatment of Cancer
    •
       Ref: E-007-2019 | Updated: Oct 06, 2020 | NCI
  • Diagnostic Assay for Determining Patient Response to Apoptosis-related Cancer Therapy
    •    Ref: E-195-2018 | Updated: Aug 01, 2019 | NCI/Leidos
  • Autophagy Modulators For Use in Treating Cancer
    •
       Ref: E-003-2018 | Updated: Aug 06, 2020 | NICHD
  • Platform to Enhance Anti-Tumor Immunity
    •
       Ref: E-053-2019 | Updated: Sep 22, 2020 | NCI
  • Design and Biological Activity of Novel Stealth Polymeric Lipid Nanoparticles for Enhanced Delivery of Hydrophobic Photodynamic Therapy Drugs
    •
       Ref: E-154-2018 | Updated: Nov 19, 2019 | NCI
  • Molecular Classification of Primary Mediastinal Large B Cell Lymphoma Using Formalin-Fixed, Paraffin-Embedded Tissue Specimens
    •
       Ref: E-172-2017 | Updated: Jan 15, 2020 | NCI
  • Combined PIKFYVE and p38 MAP Kinase Inhibition for Treating Cancer
    •    Ref: E-138-2019 | Updated: Apr 20, 2020 | NICHD
  • Therapeutic Antitumor Combination Containing TLR4 Agonist HMGN1
    •    Ref: E-069-2016 | Updated: Oct 15, 2018 | NCI
  • New Insect Sf9-ET Cell Line for Determining Baculovirus Titers
    •
       Ref: E-009-2008 | Updated: Oct 15, 2018 | NCI
  • Self-Assembling Nanoparticles Composed of Transmembrane Peptides and Their Application for Specific Intra-Tumor Delivery of Anti-Cancer Drugs
    •    Ref: E-256-2006 | Updated: Oct 23, 2018 | NCI
  • Bioluminescent Bladder Cancer Cell Line for Tracking Cancer Progression
    •    Ref: E-237-2018 | Updated: Nov 08, 2018 | NCI
  • Non-Invasive In Vivo MRI Method to Image Salient Features of Axons and Nerves
    •    Ref: E-079-2003 | Updated: Nov 14, 2018 | NICHD
  • Methods of Producing Thymic Emigrants from Induced Pluripotent Stem Cells
    •
       Ref: E-250-2016 | Updated: Aug 13, 2020 | NCI
  • Chimeric Antigen Receptor (CAR) that Targets Chemokine Receptor CCR4 and its Use in Treating Cancer
    •
       Ref: E-258-2016 | Updated: Jun 10, 2019 | NCI
  • Recombinant Virus Vectors for the Treatment of Glycogen Storage Disease type Ib (GSD-Ib)
    •
       Ref: E-072-2017 | Updated: May 15, 2019 | NICHD
  • The Biospecimen Pre-analytical Variables (BPV) Program
    •
       Ref: E-000-0001 | Updated: Jun 17, 2019 |
  • In vitro Generation of an Autologous Thymic Organoid from Human Pluripotent Stem Cells
    •
       Ref: E-133-2017 | Updated: Sep 18, 2019 | NCI
  • Efficient Methods to Prepare Hematopoietic Progenitor Cells in vitro for Therapeutic Use
    •
       Ref: E-132-2017 | Updated: Sep 18, 2019 | NCI
  • Methods for Producing Stem Cell-Like Memory T Cells for Use in T Cell-Based Immunotherapies
    •
       Ref: E-174-2012 | Updated: Apr 07, 2020 | NCI
  • Bone Marrow Mesenchymal Stem Cell (BMSC)-Derived Exosomes for the Treatment of Glaucoma
    •
       Ref: E-044-2018 | Updated: Aug 16, 2018 | NEI
  • Isotropic Generalized Diffusion Tensor MRI
    •
       Ref: E-093-2017 | Updated: Aug 16, 2018 | NICHD
  • Transformation of Weak or Non-Immunogenic Antigens to Produce an Immune Response and Therapeutic Polypeptides for the Treatment and Prevention of Cancer
    •
       Ref: E-271-2006 | Updated: Aug 23, 2018 | NIA
  • A Specialized Tissue Collection Device for the Preservation and Transportation of Needle Biopsies
    •
       Ref: E-128-2017 | Updated: Sep 05, 2018 | NCI
  • Single domain CD4, HIV-1 Antibodies, and Fusion Proteins for treatment of HIV
    •
       Ref: E-103-2010 | Updated: Sep 05, 2018 |
  • Fully Human Antibody Targeting Tumor Necrosis Factor Receptor Type 2 (TNFR2) for Cancer Immunotherapy
    •
       Ref: E-065-2017 | Updated: Sep 05, 2018 | NCI
  • Bac-2-the-Future: An Improved System for Production of Recombinant Baculovirus
    •    Ref: E-287-2012 | Updated: Oct 01, 2018 | NCI
  • Multi-Foci Sonications For Hyperthermia Treatments Using Magnetic Resource-Guided High-Intensity Focused Ultrasound (MR-HIFU)
    •
       Ref: E-013-2013 | Updated: Oct 12, 2018 | NIH CC
  • Methods For Treating or Preventing Inflammation and Periodontitis
    •
       Ref: E-015-2018 | Updated: Oct 12, 2018 | NCI
  • Bile Acids and Other Agents that Modulate the Gut Microbiome for the Treatment of Liver Cancer
    •
       Ref: E-229-2017 | Updated: Oct 12, 2018 | NCI
  • Tethered Interleukin-15 (IL-15)/IL-21 to Enhance T Cells for Cellular Therapy
    •
       Ref: E-068-2018 | Updated: Oct 12, 2018 | NCI
  • The UBE2G2 Binding Domain in the Ubiquitin Ligase GP78 and Methods of Use Thereof
    •
       Ref: E-244-2004 | Updated: Oct 12, 2018 | NCI
  • Highly Soluble Pyrimido-Dione-Quinoline Compounds: Small Molecules that Stabilize and Activate p53 in Transformed Cells
    •
       Ref: E-138-2006 | Updated: Oct 12, 2018 | NCI
  • Agonist Epitopes for the Development of a Human Papillomavirus (HPV) Therapeutic Vaccine
    •
       Ref: E-169-2016 | Updated: Oct 12, 2018 | NCI
  • Catalytically Hyperactive Variant of Human APOBEC3G Protein
    •
       Ref: E-150-2018 | Updated: Oct 15, 2018 | NCI
  • Targeted RNA/DNA Nanoparticles with Single Stranded RNA Toeholds
    •
       Ref: E-078-2016 | Updated: Jul 27, 2018 | NCI
  • Fusion Proteins as HIV-1 Entry Inhibitors
    •
       Ref: E-086-2015 | Updated: Jul 27, 2018 | NCI
  • Conformational Restriction of Cyanine Fluorophores in Far-Red and Near-IR Range
    •
       Ref: E-143-2017 | Updated: Jul 27, 2018 | NCI
  • Improved HIV Vaccines Through Ras Activation
    •
       Ref: E-062-2014 | Updated: Aug 01, 2018 | NCI
  • Renal Selective Unsaturated Englerin Analogues
    •
       Ref: E-072-2014 | Updated: Aug 01, 2018 | NCI
  • Enhanced Immunogenicity Against HIV-1 Using a DNA-prime Poxvirus Vaccination
    •
       Ref: E-157-2000 | Updated: Aug 01, 2018 | NCI
  • Nucleic Acid Nanoparticles (NANP) and Methods of Using Same for Controlled Immunomodulation
    •
       Ref: E-069-2018 | Updated: Aug 14, 2018 | NCI
  • Method for Reproducible Differentiation of Clinical Grade Retinal Pigment Epithelium Cells
    •
       Ref: E-212-2015 | Updated: Aug 14, 2018 | NEI
  • Machine Learning and/or Neural Networks to Validate Stem Cells and Their Derivatives for Use in Cell Therapy, Drug Delivery, and Diagnostics
    •
       Ref: E-058-2018 | Updated: Aug 14, 2018 | NEI
  • Topical Sodium Nitrate Ointment for Sickle Cell Disease
    •
       Ref: E-149-2014 | Updated: Aug 15, 2018 | NIH-CC
  • Robotic Exoskeleton for Treatment of Crouch Gait in Children with Cerebral Palsy (CP)
    •
       Ref: E-096-2016 | Updated: Apr 25, 2018 | CC
  • Fatty Acid Derivatives and Their Use
    •    Ref: E-151-2017 | Updated: Apr 25, 2018 | NIA
  • A peptide hydrogel for use in vascular anastomosis
    •
       Ref: E-292-2014 | Updated: Nov 27, 2019 |
  • Fully Human Antibodies and Antibody Drug Conjugates Targeting Tumor Endothelial Marker 8 (TEM8) for the Treatment of Cancer
    •
       Ref: E-344-2013 | Updated: Apr 07, 2020 | NCI
  • Establishment of Induced Pluripotent Stem Cells (iPSC) from the Thirteen-lined Ground Squirrel
    •
       Ref: E-059-2017 | Updated: Jun 26, 2018 | NEI
  • Microosmometer for the Study of a Wide Range of Biological, Macromolecular, Polymeric, Gel, or Other Samples
    •
       Ref: E-280-2002 | Updated: Jul 09, 2018 | (NICHD)
  • Methods and Compositions for Treating Genetically Linked Diseases of the Eye
    •
       Ref: E-284-2012 | Updated: Aug 13, 2020 | NEI
  • Scytovirin Domain 1 Related Polypeptides
    •    Ref: E-180-2005 | Updated: Jul 27, 2018 | NCI
  • Strategies to Protect Mammalian Neural Tissue Against Cold and Potentially Other Metabolic Stresses and Physical Damages
    •
       Ref: E-165-2017 | Updated: Oct 12, 2018 | NEI
  • A Novel Carbohydrate Antibody to GalNac1-3Gal and Its Application for Cancer Diagnostic and Prognosis
    •
       Ref: E-058-2009 | Updated: Feb 16, 2018 | NCI
  • Cancer-reactive T cells from Peripheral Blood
    •
       Ref: E-149-2015 | Updated: Feb 16, 2018 | NCI
  • Fully-human Heavy-chain-only Anti-B-cell Maturation Antigen (BCMA) Chimeric Antigen Receptors (CARs)
    •
       Ref: E-183-2017 | Updated: Mar 13, 2018 | NCI
  • Efficient Cell-Free Production of Papillomavirus Gene Transfer Vectors
    •
       Ref: E-298-2016 | Updated: Feb 12, 2019 | NCI
  • A Dendritic Cell Vaccine to Immunize Cancer Patients Against Mutated Neoantigens Expressed by the Autologous Cancer
    •
       Ref: E-280-2016 | Updated: Aug 15, 2018 | NCI
  • Combination Therapy for Prostate and Breast Cancer
    •
       Ref: E-257-2014 | Updated: Oct 27, 2017 | NCI
  • MRI-Based Method for Characterizing Axonal Microstructure in Traumatic Brain Injury
    •
       Ref: E-008-2015 | Updated: Nov 02, 2017 | NICHD
  • NSAIDs that Assist the Treatment of Human Diseases
    •
       Ref: E-131-2011 | Updated: Feb 21, 2018 | NCI
  • T Cell Receptors Targeting KRAS Mutants for Cancer Immunotherapy/Adoptive Cell Therapy
    •
       Ref: E-175-2016 | Updated: Jul 21, 2020 | NCI
  • Schweinfurthins and Uses Thereof
    •
       Ref: E-183-2009 | Updated: Mar 20, 2018 | NCI
  • Methods of Producing Effective T-cell Populations Using Akt Inhibitors
    •
       Ref: E-013-2016 | Updated: Dec 05, 2017 | NCI
  • Treatment Regimens for hetIL-15
    •    Ref: E-126-2016 | Updated: Dec 06, 2017 | NCI
  • Therapeutics for Neurodegenerative Disorders and Cancer Using Lenalidomide Analogs
    •
       Ref: E-045-2012 | Updated: Apr 03, 2018 | NIA
  • IL7Rα-Specific Antibody for Treating Acute Lymphoblastic Leukemia (ALL)
    •
       Ref: E-247-2015 | Updated: Jan 17, 2018 | NCI
  • Conserved Elements Vaccine for HIV
    •    Ref: E-132-2012 | Updated: Jun 28, 2019 | NCI
  • MADCO-Accelerated Multidimensional Diffusion MRI
    •
       Ref: E-173-2016 | Updated: Dec 07, 2017 | NICHD
  • Method to Reduce the Bias in the Mean and Variance of Indices of Water Diffusion Anisotropy as Measured by Diffusion Tensor MRI
    •
       Ref: E-157-1996-0 | Updated: Sep 16, 2015 | NINDS
  • Nucleic Acid Nanoparticles for Triggering RNA Interference
    •
       Ref: E-156-2014 | Updated: Apr 07, 2020 | NCI
  • Functionally-Interdependent Shape-Switching Nucleic Acid Nanoparticles
    •
       Ref: E-277-2016 | Updated: Oct 23, 2017 | NCI
  • Cancer Therapeutic Based on Hypoxia Inducible Factor 1 (HIF-1) Inhibitors
    •
       Ref: E-115-2015 | Updated: Apr 18, 2017 | NCI
  • Compounds that Interfere with the Androgen Receptor Complex
    •
       Ref: E-162-2009 | Updated: Aug 17, 2020 | NCI
  • Prognostic Biomarkers for Patients with Early Stage Lung Cancer
    •    Ref: E-048-2012 | Updated: Apr 09, 2018 | NCI
  • Vaccine for BK Polyomavirus-associated Infections in Transplant Recipients
    •
       Ref: E-168-2011 | Updated: Mar 21, 2018 | NCI
  • Clinical Outcome Predictors for Mantle Cell Lymphoma
    •
       Ref: E-131-2016 | Updated: Oct 25, 2017 | NCI
  • Small Molecule Anti-cancer Agents that Stabilize the MYC-G-Quadruplex
    •
       Ref: E-053-2015 | Updated: Apr 03, 2018 | NCI
  • A New Class of Stable Heptamethine Cyanine Fluorophores and Biomedical Applications Thereof
    •
       Ref: E-271-2014 | Updated: Mar 20, 2018 | NCI
  • Combination Cancer Therapy with HDAC Inhibitors
    •
       Ref: E-065-2016 | Updated: Apr 03, 2018 | NCI
  • Niclosamide for Treating Adrenocortical Cancer (ACC)
    •
       Ref: E-089-2016 | Updated: Jul 16, 2018 | NCI
  • Non-invasive Methods for Characterizing Adrenocortical Tumors
    •
       Ref: E-193-2015 | Updated: Apr 07, 2020 | NCI
  • A Sensitive, High Throughput Pseudovirus-Based Papillomavirus Neutralization Assay for HPV 16 and HPV 18
    •
       Ref: E-137-2004 | Updated: Jul 19, 2018 | NCI
  • Anti-bacterial Treatments Using Peptide-Based Inhibitors of the STAT3-IL10 Pathway
    •
       Ref: E-278-2014 | Updated: Jan 18, 2017 | NCI
  • Anti-Py1235-Met Immunological Binding Reagent as Cancer Diagnostic
    •
       Ref: E-130-2016 | Updated: Feb 13, 2017 | NCI
  • New T-Cell Immunotherapy that Targets Aggressive Epithelial Tumors
    •
       Ref: E-153-2016 | Updated: Mar 02, 2017 | NCI
  • Devices for Improved Tissue Cryopreservation and Recovery
    •
       Ref: E-094-2016 | Updated: Apr 13, 2020 | NEI
  • Treatment of GPR101-Related, Growth Hormone-Related Disorders Such as Gigantism, Dwarfism or Acromegaly
    •
       Ref: E-039-2016 | Updated: Jan 03, 2019 | NICHD

    Pages


    Displaying 701 - 800 of 1134

    Category Index

    Office of Technology Transfer, Office of Intramural Research, National Institutes of Health

    6011 Executive Blvd, Suite 325, Rockville, MD 20852 | Phone: 301-496-7057